(Q40725231)

English

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation (English)

1 reference

Europe PubMed Central

23 September 2017

1 reference

based on heuristic

inferred from title

author name string

Thomas Hoffmann

1

1 reference

Europe PubMed Central

23 September 2017

Charlotte Russell

2

1 reference

Europe PubMed Central

23 September 2017

Lars Vindelov

3

1 reference

Europe PubMed Central

23 September 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

23 September 2017

Acta Pathologica et Microbiologica Scandinavica

1 reference

Europe PubMed Central

23 September 2017

110

1 reference

Europe PubMed Central

23 September 2017

2

1 reference

Europe PubMed Central

23 September 2017

148-157

1 reference

Europe PubMed Central

23 September 2017

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Insertion of SMRV-H viral DNA at the c-myc gene locus of a BL cell line and presence in established cell lines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2002.100205.X

21 January 2018

Identifiers

10.1034/J.1600-0463.2002.100205.X

1 reference

Europe PubMed Central

23 September 2017

release_6qra2pj6bndaxnb6hqfqktkhiy

1 reference

https://api.fatcat.wiki/v0/release/6qra2pj6bndaxnb6hqfqktkhiy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40725231&oldid=1905182118"